Blue Chip Partners’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,301
Closed -$550K 188
2026
Q1
$550K Buy
+10,301
New +$605K 0.04% 114
2023
Q3
Sell
-2,125
Closed -$120K 184
2023
Q2
$120K Buy
2,125
+2
+0.1% +$110 0.01% 175
2023
Q1
$115K Sell
2,123
-2,588
-55% -$138K 0.01% 169
2022
Q4
$248K Buy
+4,711
New +$239K 0.03% 125

Other funds holding IHI

Blue Chip Partners's IHI Position: Q2 2026 in Review

Blue Chip Partners sold out of iShares US Medical Devices ETF (IHI) in Q2 2026, closing a stake of 10,301 shares — an estimated $550K sold.

Blue Chip Partners first reported a position in IHI in Q4 2022 and held it in 4 quarters. The position peaked at $550K in Q1 2026. 503 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Blue Chip Partners reported no remaining iShares US Medical Devices ETF position as of Q2 2026 after selling out during the quarter.
  • Blue Chip Partners sold 10,301 iShares US Medical Devices ETF shares in Q2 2026, an estimated $550K.
  • Blue Chip Partners first reported a position in iShares US Medical Devices ETF in Q4 2022 and held it in 4 quarters.
  • Blue Chip Partners's iShares US Medical Devices ETF position peaked at $550K in Q1 2026.
  • 503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Blue Chip Partners's 13F filing for Q2 2026, filed 14 Aug 2026.